人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白

ATC L04AB · 1 markets · 8 records

人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白 1 markets · 8 records Forms

CN 8 records · 2 strengths

  • 25 mginjection益赛普人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白__mah__:三生国健药业(上海)股份有限公司、__mah__:上海赛金生物医药有限公司、__mah__:杭州博之锐生物制药有限公司
  • 12.5 mginjection益赛普人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白__mah__:杭州博之锐生物制药有限公司
The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.